NCT03362151

Brief Summary

The aim of this clinical study is to investigate and compare the postprandial glycemic response to three different meal types rich in carbohydrates, that is, white pasta, high protein pasta and white rice consumed by individuals with T1DM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 5, 2017

Completed
27 days until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2018

Completed
Last Updated

September 5, 2018

Status Verified

September 1, 2018

Enrollment Period

7 months

First QC Date

November 29, 2017

Last Update Submit

September 4, 2018

Conditions

Keywords

type 1 diabetespastariceproteincarbohydrate

Outcome Measures

Primary Outcomes (1)

  • Delta glucose (maximum rise from baseline glucose) mg/dL

    Delta glucose (maximum rise from baseline glucose) from the start of the meal to the peak continuous glucose monitoring (CGM) glucose reading (mg/dL) during the 5-hour postprandial window, compared between the three meal types.

    5 hours

Secondary Outcomes (3)

  • Incremental area under the curve (area)

    5 hours

  • Time to peak glucose level (minutes)

    5 hours

  • percent time glucose <70 mg/dL

    5 hours

Study Arms (3)

Regular pasta

EXPERIMENTAL

Subjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of regular pasta. They will consume this meal on two separate occasions.

Other: Regular pasta

High protein pasta

EXPERIMENTAL

Subjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of high protein pasta. They will consume this meal on two separate occasions.

Other: High protein pasta

White rice

EXPERIMENTAL

Subjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of white rice. They will consume this meal on two separate occasions.

Other: White rice

Interventions

Regular pasta (Approximately 42 grams carbohydrate per meal)

Regular pasta

High protein pasta (Approximately 38 grams carbohydrate per meal)

High protein pasta

White rice (Approximately 43 grams carbohydrate per meal)

White rice

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 and ≤ 75 years at the time of screening.
  • Clinical diagnosis of type 1 diabetes for at least one year.
  • HbA1c ≤ 10%, as performed by point of care or central laboratory testing. A1c will be assessed at the screening visit, or if already completed within 2 months of the screening visit, the prior lab value may be used in lieu of repeating this assessment.
  • Currently using insulin-to-carbohydrate ratio to calculate meal bolus sizes, and boluses for all meals and snacks that contain ≥ 5 grams of carbohydrate.
  • Willing to refrain from taking acetaminophen products for the duration of the clinical trial. If acetaminophen is taken, subject is to avoid making any insulin dosing decisions based on CGM for at least 12 hours.
  • For females, not currently known to be pregnant. If female and sexually active, must agree to use a form of contraception to prevent pregnancy while a participant in the study. A negative urine pregnancy test will be required for all premenopausal women who are not surgically sterile at the screening visit. Subjects who become pregnant will be discontinued from the study.
  • Willing to abide by the study protocol and use study-provided devices.

You may not qualify if:

  • Gastrointestinal disease such as celiac disease or multiple food allergies.
  • Any form of gluten sensitivity or wheat allergy.
  • Allergies to any form of nuts and ingredients present in the study meals (tomatoes etc).
  • History of gastroparesis.
  • Pregnancy.
  • Dermatological conditions that would preclude wearing a CGM sensor.
  • Screening A1c \> 10%.
  • Any condition that could interfere with participating in the trial, based on the investigator's judgment.
  • A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol.
  • Participation in another pharmaceutical or device trial at the time of enrollment or during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sansum Diabetes Research Institute

Santa Barbara, California, 93105, United States

Location

Related Publications (1)

  • Zavitsanou S, Massa J, Deshpande S, Pinsker JE, Church MM, Andre C, Doyle Iii FJ, Michelson A, Creason J, Dassau E, Eisenberg DM. The Effect of Two Types of Pasta Versus White Rice on Postprandial Blood Glucose Levels in Adults with Type 1 Diabetes: A Randomized Crossover Trial. Diabetes Technol Ther. 2019 Sep;21(9):485-492. doi: 10.1089/dia.2019.0109. Epub 2019 Jun 21.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • David Eisenberg, MD

    Harvard School of Public Health (HSPH)

    PRINCIPAL INVESTIGATOR
  • Eyal Dassau, PhD

    Harvard University

    PRINCIPAL INVESTIGATOR
  • Jordan E Pinsker, MD

    Sansum Diabetes Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Subjects will not be told which meal they are eating.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Subjects will consume pre-determined meals on 6 difference occasions. There will be three categories of "study meals" consisting of: 1. Regular pasta (42 grams carbohydrate per meal) 2. High protein pasta (38 grams carbohydrate per meal) 3. White rice (43 grams carbohydrate per meal) Each subject will consume each meal on two separate occasions in random order.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2017

First Posted

December 5, 2017

Study Start

January 1, 2018

Primary Completion

August 2, 2018

Study Completion

August 2, 2018

Last Updated

September 5, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Locations